ARCHIVES

FDA Committee IK IL-2/LAK For Modified Group C

This article is from The Cancer Letter archive.

Vol. 13 No. 18 | May 1, 1987

Download PDF Visit The Full Archive

Related Articles

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006

Clinical Trials Approved By NCI In November

December 28, 2001